Kim, C., Wang, X.-D., Liu, Z., Hao, J., Wang, S., Li, P., Zi, Z., Ding, Q., Jang, S., Kim, J., Luo, Y., Huffman, K. E., Pal Choudhuri, S., del Rio, S., Cai, L., Liang, H., Drapkin, B. J., Minna, J. D., & Yu, Y. (2024). Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors. Science Advances, 10(3). https://doi.org/10.1126/sciadv.adh2579